Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112930348A details an enzymatic route for Safraninib, improving yield and reducing waste compared to chiral resolution methods.
Patent CN104497130A reveals a novel 2+6 segment condensation method for Lanreotide, enhancing purity and yield for cost-effective peptide manufacturing supply chains.
Novel 4-step synthesis of Oseltamivir Phosphate using Ritter reaction. High yield, mild conditions, and cost-effective API manufacturing solution for global supply chains.
Novel microwave-assisted method for Caspofungin Acetate synthesis. High yield, reduced time. Ideal for antifungal API manufacturing and supply chain optimization.
Novel fragment condensation method for Gelpaglutide improves crude purity to over 75 percent and total yield to nearly 30 percent, offering significant cost reduction in polypeptide manufacturing.
Patent CN101274923B reveals a novel nitrate-catalyzed method for selective acylation, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111116501B details a novel catalytic method for synthesizing Lesinurad intermediates, eliminating chlorinated impurities and ensuring scalable API production.
Patent CN112250611B reveals a novel Friedel-Crafts route for Larotrectinib intermediates. Achieve high purity and cost reduction in API manufacturing with scalable chemistry.
Advanced synthesis of low-cardiotoxicity anthracycline intermediates via novel reductive amination. Optimized for scale-up and purity in API manufacturing.
Discover a novel SO2-catalyzed synthesis for high-purity mometasone furoate. This patent-backed process offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN106749528B reveals a novel one-step HPLC method for octreotide, integrating cyclization and purification to drastically reduce manufacturing costs and lead time.
Novel preparation method of Neratinib avoiding toxic chlorination. Cost-effective, scalable API intermediate manufacturing process for pharmaceutical supply chains.
Patent CN103288804A reveals a streamlined one-step condensation for Nilotinib, offering superior atom economy and simplified supply chains for API manufacturers.
Patent CN112521482A reveals a solid-liquid combined method for nesiritide. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Novel semi-synthetic process for taxane derivatives using activated oxazoles. Offers improved yield and purity for API manufacturing.
Patent CN112174970B reveals a scalable method for Pemetrexed Disodium using alkali-modified molecular sieves, ensuring high yield and reduced environmental impact.
Patent CN113024521B reveals a streamlined 5-step synthesis for Entrectinib, offering high purity and mild conditions for reliable API intermediate supply chains.
Patent CN119504367A reveals a high-yield Benvimod route. This analysis details cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Patent CN102050775A details a novel method for synthesizing and isolating a critical succinimide-based impurity of Anastrozole, ensuring robust quality control and supply chain reliability for API manufacturers.
Patent CN108676086A reveals novel Depsipeptide strategy for Liraglutide. Enhances purity, yield, and supply chain reliability for global pharmaceutical procurement.